Sophie Cousins a Devex Contributor based in South Asia. She is a health journalist focused on women and girls. She was previously based between Lebanon and Iraq, focusing on refugee health and conflict. She writes for international medical journals, including The Lancet, and for international news websites such as the Guardian.
Each year around 70,000 women die due to excessive bleeding after childbirth, known as postpartum hemorrhage. A new, heat-stable drug called carbetocin could have the potential to save tens of thousands of lives.
The country with the world’s largest tuberculosis burden this week launched an ambitious plan to eradicate the deadly disease five years ahead of the global target. But many doubt whether that goal can be attained.
A new roadmap for fighting the disease — which humans contract from sick animals, meat, and dairy products — spells out goals aimed at catalyzing political energy and attention in a fight that is lagging behind.
Seeking new funding for the fight against tuberculosis, The Global Fund to Fight AIDS, Tuberculosis and Malaria and the International Union against Tuberculosis and Lung Disease last week announced a partnership to spur new private sector investment.
A new vaccine developed by the Serum Institute in India has been shown to be more effective than existing options and can survive in high temperature environments. The promising breakthrough demonstrates India's growing role in both drug production and, increasingly, development.